Whittier Trust Co. Acquires 325 Shares of West Pharmaceutical Services Inc. (NYSE:WST)

Whittier Trust Co. grew its holdings in West Pharmaceutical Services Inc. (NYSE:WST) by 1.1% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 30,250 shares of the medical instruments supplier’s stock after acquiring an additional 325 shares during the period. Whittier Trust Co.’s holdings in West Pharmaceutical Services were worth $4,290,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in WST. Krane Funds Advisors LLC bought a new position in West Pharmaceutical Services in the second quarter worth approximately $26,000. Steward Partners Investment Advisory LLC bought a new position in West Pharmaceutical Services in the second quarter worth approximately $40,000. Machina Capital S.A.S. bought a new position in West Pharmaceutical Services in the second quarter worth approximately $42,000. Advisory Services Network LLC raised its position in West Pharmaceutical Services by 84.5% in the second quarter. Advisory Services Network LLC now owns 393 shares of the medical instruments supplier’s stock worth $49,000 after acquiring an additional 180 shares during the period. Finally, FMR LLC raised its position in West Pharmaceutical Services by 41.3% in the first quarter. FMR LLC now owns 794 shares of the medical instruments supplier’s stock worth $88,000 after acquiring an additional 232 shares during the period. Institutional investors and hedge funds own 91.13% of the company’s stock.

Several research analysts have weighed in on the stock. Bank of America upgraded shares of West Pharmaceutical Services from an “underperform” rating to a “neutral” rating in a research report on Friday, July 26th. ValuEngine downgraded shares of West Pharmaceutical Services from a “buy” rating to a “hold” rating in a research report on Wednesday, October 2nd. Finally, Zacks Investment Research upgraded shares of West Pharmaceutical Services from a “hold” rating to a “strong-buy” rating and set a $158.00 price objective on the stock in a research report on Saturday, August 3rd. Three investment analysts have rated the stock with a hold rating, one has given a buy rating and one has issued a strong buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average price target of $130.72.

NYSE:WST traded down $0.37 during trading hours on Monday, hitting $140.48. 1,517 shares of the company were exchanged, compared to its average volume of 393,758. The stock has a market capitalization of $10.44 billion, a price-to-earnings ratio of 50.01, a PEG ratio of 4.02 and a beta of 1.28. West Pharmaceutical Services Inc. has a 52-week low of $91.75 and a 52-week high of $152.10. The company has a debt-to-equity ratio of 0.18, a current ratio of 3.02 and a quick ratio of 2.27. The company’s 50 day moving average price is $143.18 and its 200-day moving average price is $129.00.

West Pharmaceutical Services (NYSE:WST) last released its earnings results on Thursday, July 25th. The medical instruments supplier reported $0.89 earnings per share for the quarter, topping the consensus estimate of $0.72 by $0.17. The company had revenue of $469.70 million for the quarter, compared to the consensus estimate of $459.90 million. West Pharmaceutical Services had a net margin of 12.94% and a return on equity of 16.93%. West Pharmaceutical Services’s revenue was up 5.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.70 EPS. On average, equities analysts predict that West Pharmaceutical Services Inc. will post 3.06 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, November 6th. Stockholders of record on Wednesday, October 23rd will be issued a $0.15 dividend. This represents a $0.60 annualized dividend and a dividend yield of 0.43%. The ex-dividend date of this dividend is Tuesday, October 22nd. West Pharmaceutical Services’s dividend payout ratio (DPR) is currently 21.35%.

West Pharmaceutical Services Profile

West Pharmaceutical Services, Inc manufactures and sells containment and delivery systems for injectable drugs and healthcare products in the United States, Germany, France, Other European countries, South Korea, and internationally. The company operates through two segments, Proprietary Products and Contract-Manufactured Products.

Featured Article: What type of investment options does a Roth IRA provide?

Institutional Ownership by Quarter for West Pharmaceutical Services (NYSE:WST)

Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.